Overview
LivingMed Biotech's mission is to develop and commercialize the world's first oral vaccine for avian influenza, combining breakthrough science with practical delivery methods. The company aims to simplify disease prevention for poultry producers, reduce economic losses, and mitigate zoonotic risks by addressing limitations of traditional vaccines that are difficult to produce, transport, and administer.
Key people
Related profiles
Something wrong or missing? Send an update. Fixed within 24 hours.